UroGen Pharma Ownership | Who Owns UroGen Pharma?
UroGen Pharma Ownership Summary
UroGen Pharma is owned by 87.82% institutional investors, 8.40% insiders, and 3.78% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 10.66% of URGN shares. BioPharma Credit Ord is the top mutual fund, with 10.18% of its assets in UroGen Pharma shares.
URGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | UroGen Pharma | 87.82% | 8.40% | 3.78% |
| Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
| Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 3.56M | 10.66% | $59.69M |
| Adage capital partners gp | 2.93M | 6.79% | $31.18M |
| Blackrock | 2.19M | 6.57% | $36.81M |
| Cowen and company | 2.10M | 6.29% | $35.23M |
| Blackrock funding, inc. /de | 2.47M | 5.72% | $26.28M |
| Morgan stanley | 1.84M | 5.51% | $30.85M |
| Menora mivtachim | 2.30M | 5.34% | $24.53M |
| Toronto dominion bank | 1.75M | 4.06% | $18.63M |
| Vestal point capital, lp | 1.63M | 3.78% | $17.36M |
| Ubs asset management americas | 1.38M | 3.20% | $14.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 870.00K | 4.74% | $9.27M |
| Stonepine capital management | 324.32K | 2.79% | $3.45M |
| Superstring capital management lp | 301.21K | 2.78% | $3.21M |
| Silverarc capital management | 1.12M | 2.61% | $11.93M |
| Wildcat capital management | 495.61K | 2.09% | $5.28M |
| Dafna capital management | 492.51K | 1.33% | $5.25M |
| Vestal point capital, lp | 1.63M | 1.03% | $17.36M |
| Cowen and company | 2.10M | 0.97% | $35.23M |
| Rtw investments, lp | 3.56M | 0.92% | $59.69M |
| Nantahala capital management | 1.37M | 0.63% | $14.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Toronto dominion bank | 1.75M | 0.03% | 1.75M |
| Morgan stanley | 1.84M | 0.00% | 1.45M |
| Nantahala capital management | 1.37M | 0.63% | 1.37M |
| Vestal point capital, lp | 1.63M | 1.03% | 1.23M |
| Ubs group | 922.70K | 0.00% | 876.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.08M |
| Point72 asset management | 317.11K | 0.01% | -1.19M |
| Millennium management | 645.78K | 0.00% | -853.42K |
| Adage capital partners gp | 2.93M | 0.05% | -807.65K |
| Cormorant asset management, lp | - | - | -300.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nantahala capital management | 1.37M | 0.63% | 1.37M | $14.61M |
| Rosalind advisors | 870.00K | 4.74% | 870.00K | $9.27M |
| Cantor fitzgerald, l. p. | 360.00K | 0.08% | 360.00K | $3.79M |
| Superstring capital management lp | 301.21K | 2.78% | 301.21K | $3.21M |
| Hudson bay capital management lp | 233.32K | 0.01% | 233.32K | $2.48M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Signaturefd | -22.00 |
| Us bancorp \de\ | -47.00 |
| Systm wealth solutions | -48.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 143 | 2.14% | 41,643,982 | 14.80% | 87 | 1.24% | 64 | -11.11% | 49 | 25.64% |
| Dec 31, 2024 | 101 | -23.48% | 19,804,522 | -43.62% | 45 | 0.69% | 52 | -30.67% | 26 | -13.33% |
| Sep 30, 2024 | 132 | 9.09% | 35,128,434 | -8.10% | 81 | 0.76% | 75 | -5.06% | 30 | 50.00% |
| Jun 30, 2024 | 120 | 2.56% | 38,225,515 | 40.73% | 114 | 2.03% | 78 | 56.00% | 20 | -45.95% |
| Mar 31, 2024 | 117 | 8.33% | 27,162,135 | 26.89% | 75 | 1.71% | 50 | -24.24% | 37 | 85.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 4.69M | 10.18% | 4.69M |
| UBS (Lux) Digital Health Equity SB USD | 1.32M | 2.86% | - |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.25M | 2.71% | - |
| iShares Russell 2000 ETF | 928.59K | 2.01% | 6.44K |
| International Biotechnology Ord | 427.15K | 0.93% | -34.85K |
| Fidelity Small Cap Index | 390.01K | 0.85% | 5.97K |
| iShares Russell 2000 Growth ETF | 266.93K | 0.58% | 658.00 |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 262.40K | 0.57% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 262.40K | 0.57% | - |
| iShares Biotechnology ETF | 240.10K | 0.52% | -867.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 09, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $38.04K |
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $21.12K |
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $8.46K |
| Jan 31, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | $21.12K |
| Jan 31, 2025 | Smith Jason Drew | General Counsel | Sell | $30.82K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 6 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
URGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools